CarePoint Health signs letter of intent to sell Bayonne Medical Center…

first_img Facebook Twitter Share on Facebook Tweet on Twitter Bayonne Previous articleDespite COVID-19, Jersey City Council to still hold meetings remotely via Microsoft TeamsNext articleCity of Union City announces 14 patients diagnosed with coronavirus John Heinis CarePoint Health has signed a letter of intent to sell the Bayonne Medical Center to a new company, BMC Hospital LLC, with the sale hinging on the New Jersey Department of Health, the City of Bayonne, and/or the Hudson County Improvement Authority. By John Heinis/Hudson County View“CarePoint Health and BMC Hospital LLC are pleased to announce that they signed a letter of intent concerning the sale and preservation of Bayonne Medical Center as an acute care hospital,” CarePoint spokesman Eric Bloom said in a statement.“The transaction is contingent on approvals from the Department of Health, and either a simultaneous purchase of the real estate by an affiliated entity or the City of Bayonne and/or Hudson County Improvement Authority exercising its right to eminent domain related to the Hospital real estate.”He also said that Bayonne and the HCIA are discussing “the appropriate steps to eminent” domain the aforementioned property.BMC Hospital LLC, who boasts over 50 years of experience operating healthcare facilities – including some in the New York Metropolitan region – expressed excitement about operating in Bayonne.“Bayonne is a vibrant, growing community with a great history that the Bayonne Medical Center has always been part of, and should continue to be into the future,” the company said in the same statement.“We look forward to making sure that happens for the citizens, patients, doctors, nurses and others to whom the hospital is so important.”Bayonne Assemblyman Nick Chiaravalloti (D-31), who introduced a financial transparency bill last year after the CarePoint owners were alleged to have been paid $157 million in management fees, also had positive remarks about the latest development.“I welcome the news that CarePoint-Bayonne has signed a Letter of Interest with a prospective purchaser of Bayonne Medical Center. The COVID-19 pandemic has proven what I always knew – Bayonne needs a full-service acute care hospital.”Back in October, Hudson County officials said they would fight against any CarePoint sale that would close the BMC, with many of those officials – plus many others – reconvening earlier this month to claim Alaris Health was holding up hospital sales by asking for $300 million for land they acquired for $51 million.To that end, Bloom said that CarePoint and RWJ Barnabas Health had reached a deal to sell Christ Hospital in Jersey City and the Hoboken University Medical Center, but Avery Eisenreich, the owner of Alaris, killed the deal.“CarePoint Health separately reached agreement with RWJ Barnabas Health, Inc. on all material terms to sell Christ Hospital and Hoboken University Medical Center but Avery Eisenreich refused to accept reasonable offers that will allow the transaction to move forward.”Alaris and Eisenreich could not immediately be reached for comment. CarePoint Health reaches deal for Cigna Health Insurance to join their network CarePoint Health signs letter of intent to sell Bayonne Medical Center to new company Bayonne 1 COMMENT RELATED ARTICLESMORE FROM AUTHOR TAGSbayonne medical centercarepoint healthletter of intent SHAREcenter_img Bayonne man pepper sprayed, arrested after punching cop in the face, authorities say Best trees you can fine in Hawai ! Bayonne man busted with cocaine, heroin, semi-automatic handgun after fleeing from cops baccarat Comments are closed. By John Heinis – March 23, 2020 6:18 pm 1 March 30, 2020 3:07 pm at 3:07 pm Bayonne BayonneCommunityNewslast_img read more

First American With Drug-Resistant Epilepsy Has Great Success With Newly-Approved ‘Brain Stimulation’

first_imgAddThis Sharing ButtonsShare to FacebookFacebookFacebookShare to TwitterTwitterTwitterShare to EmailEmailEmailShare to RedditRedditRedditShare to MoreAddThisMoreFor the first time in America since the procedure was approved for commercial use last year, scientists have successfully treated a patient for drug-resistant epilipsy with a technique called “deep brain stimulation” (DBS).DBS is a minimally-invasive surgical therapy that uses an implanted medical device, similar to a cardiac pacemaker, to deliver electrical stimulation to precisely targeted areas of the brain as adjunctive treatment for several neurological disorders – including depression.In April 2018, the FDA granted pre-market approval for Medtronic DBS therapy as adjunctive treatment for reducing the frequency of partial-onset seizures in individuals 18 years of age or older who are drug-resistant to three or more anti-epileptic medications. The approval was based on results from the SANTE trial (Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy), where patients had a median seizure frequency reduction of 75% at seven years post-implant.RELATED: Exciting New Study Shows That Zapping the Brain ‘Acutely’ Relieves Symptoms of DepressionDuring DBS, thin stimulation electrodes are placed into deep regions of the brain that control various functions. A pacemaker implanted in the chest sends electrical impulses through the electrodes, which regularizes abnormal brain activity and alleviates symptoms.DBS therapy for epilepsy delivers controlled electrical pulses to a target in the brain called the anterior nucleus of the thalamus (ANT), which is part of a network involved in seizures.Dr. Robert E. Gross completed the first case in the U.S. since the procedure was FDA-approved and made available commercially. That procedure was conducted at Emory University Hospital in November 2018 – and according to a university statement in February, the patient is doing well.WATCH: He Was Called Foolish for His Research; Now Documentary Tells How He Won Nobel Prize for ‘Cancer Cure’“The commercial availability of DBS provides an important surgical treatment option for patients who suffer from epilepsy and do not respond to medication,” says Gross. “ANT DBS has been shown to significantly reduce the frequency and severity of seizures and improve quality of life out to seven years.”“While it has only been two months since the system was turned on, his frequency of seizures has declined by more than 50%, and we expect improvement to increase further with additional programming sessions.”The second case at Emory took place on February 21st and researchers are eager to witness its continued success.CHECK OUT: Years After She Smells Parkinson’s Disease on Her Husband, Woman is Now Paving the Way for Early Detection TestAccording to the American Epilepsy Society, as many as three million Americans have epilepsy. Antiepileptic drug (AED) medication is the primary treatment to control seizures; however, approximately one third of individuals with epilepsy have seizures that do not successfully respond to AEDs. In the SANTE trial, all subjects had tried at least three AEDs and, on average, lived with epilepsy for 22 years prior to treatment with DBS.The Medtronic DBS System for Epilepsy has demonstrated safety and effectiveness in patients who averaged six or more seizures per month over the three most recent months (with no more than 30 days between seizures) and has not been evaluated in patients with less frequent seizures.In addition to medically refractory epilepsy, DBS therapy is currently approved in many locations around the world, including the United States and Europe, for the treatment of the disabling symptoms of essential tremor and Parkinson’s disease.(Reprinted from Emory University)Treat Your Friends With A Daily Dose Of Good News By Sharing This To Social Media…AddThis Sharing ButtonsShare to FacebookFacebookFacebookShare to TwitterTwitterTwitterShare to EmailEmailEmailShare to RedditRedditRedditShare to MoreAddThisMorelast_img read more

YIFFY: celebrating young professionals

first_imgThis year’s award went to Evgeniya Khokhlova, who represents the Russian Association of Forwarding and Logistic Organizations and is a specialist in project logistics at SVH-Freight.Khokhlova beat three other regional finalists selected from entrants around the world. Her prize is two one-week training sessions with insurance and risk management service provider TT Club at one of its regional headquarters in London, New Jersey or Hong Kong.The other three finalists were: Enos Chapara, tracking and documentation agent at Bollore Transport and Logistics Zimbabwe, representing Shipping and Forwarding Agents’ Association of Zimbabwe; Rachel van Harmelen, business unit sales manager at DSV Panalpina in Canada, representing the Canadian International Freight Forwarders Association; and Phillip Burgess, South Island manager at Burnard International in New Zealand, representing Customs Brokers and Freight Forwarders Federation of New Zealand.The TT Club-sponsored 2020 YIFFY Award will be presented at next year’s FIATA Congress in Busan, South Korea on October 19-24.YIFFY candidates must submit a 6,000-word dissertation outlining the pertinent details of an import and export shipment from their native country. The four finalists will then present their dissertations in person to a panel of judges at the Congress, where the overall winner will be selected.www.ttclub.comfiata.comlast_img read more

Farmington Hills clerk’s office announces election hours

first_imgThe Farmington Hills City Clerk’s Office this week announced extended hours for business related to the August 4 Primary Election.Located inside City Hall, 31555 W. 11 Mile Rd., the office is normally open Monday-Friday, 8:30 a.m.-4:30 p.m. Additional hours include:Monday, July 20-Thursday, July 23 – 8:30 a.m.-7 p.m.Monday, July 27-Thursday, July 30 – 8:30 a.m.-7 p.m.Saturday, August 1 – 8:30 a.m.-4:30 p.m.To learn more, call 248-871-2410.The Clerk’s office also released this video to clarify information about Absent Voter ballots, which started going out in the mail this week:There’s still time to request a ballot. Visit to learn more. Reported by jonihubred Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Pinterest (Opens in new window)last_img read more